GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
8AP6 | Q583U4 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
8AP6 | 8AP6 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
2FHR | 2894810 | Trypanosoma Rangeli Sialidase In Complex With 2,3- Difluorosialic Acid (Covalent Intermediate) | |
6TS2 | G0SB58 | Truncated version of Chaetomium thermophilum UDP-Glucose Glucosyl Transferase (UGGT) lacking domain TRXL2 (417-650). | |
6QUB | Q9F4D5 | Truncated beta-galactosidase III from Bifidobacterium bifidum in complex with galactose | |
7N3T | P04629 | TrkA ECD complex with designed miniprotein ligand | |
7N3T | 7N3T | TrkA ECD complex with designed miniprotein ligand | |
1E40 | P00692 | Tris/maltotriose complex of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 2.2A | |
1E40 | P06278 | Tris/maltotriose complex of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 2.2A | |
7LWW | P0DTC2 | Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y) | |
8PUV | P14336 | Trimeric prM/E spike of Tick-borne encephalitis virus immature particle | |
2EI4 | P29563 | Trimeric complex of archaerhodopsin-2 | |
7NTA | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect) | |
7NT9 | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation) | |
7NTC | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab | |
7NTC | 7NTC | Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab | |
5UP2 | C0KD18 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UP2 | B7ZSK1 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UP2 | A7XY94 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UP2 | 5UP2 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UOW | C0KD18 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UOW | B7ZSK1 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UOW | A7XY94 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UOW | 5UOW | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
6MMX | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMX | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMS | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | |
6MMS | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | |
6MMW | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMW | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMU | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMU | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMT | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMT | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMV | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
6MMV | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
5ELI | Q9NZC2 | Triggering receptor expressed on myeloid cells 2 | |
6D6F | P00698 | Triclinic lysozyme cryocooled to 100 K with 47% xylose as cryoprotectant | |
1MS9 | Q26964 | Triclinic form of Trypanosoma cruzi trans-sialidase, in complex with lactose | |
1MS8 | Q26964 | Triclinic form of Trypanosoma cruzi trans-sialidase, in complex with 3-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA) | |
8OIA | A2FTT0 | Trichomonas vaginalis riboside hydrolase in complex with D-ribose | |
6HKU | E2ESL7 | Trichodysplasia spinulosa-associated polyomavirus (TSPyV) VP1 in complex with sialylated precision glycooligomers | |
4U60 | E2ESL7 | Trichodysplasia spinulosa-associated polyomavirus (TSPyV) VP1 in complex with GM1 oligosaccharide | |
4U61 | E2ESL7 | Trichodysplasia spinulosa-associated polyomavirus (TSPyV) VP1 in complex with 6'-sialyllactose | |
4U62 | E2ESL7 | Trichodysplasia spinulosa-associated polyomavirus (TSPyV) VP1 in complex with 3'-sialyllactose | |
4PSE | G0RH85 | Trichoderma reesei cutinase in complex with a C11Y4 phosphonate inhibitor | |
7OC8 | P62694 | Trichoderma reesei Cel7A E212Q mutant in complex with pNPL | |
7NYT | P62694 | Trichoderma reesei Cel7A E212Q mutant in complex with lactose. | |
7NDE | A0A2H2ZFD4 | Trichoderma parareesei PL7A beta-glucuronan lyase | |
6VEJ | 6VEJ | TriABC transporter from Pseudomonas aeruginosa |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024